论文部分内容阅读
目的 观察莫西沙星注射液联合痰热清注射液治疗老年社区获得性肺炎(CAP)的临床效果及安全性.方法 将70例老年CAP患者随机分为观察组和对照组,每组35例.观察组予以莫西沙星注射液联合痰热清注射液静脉滴注,每天1次;对照组仅给予莫西沙星注射液静脉滴注,每天1次,2组疗程均为10 d.观察2组患者的临床疗效、细菌清除率及不良反应发生情况.结果 观察组痊愈率为68.6%,总有效率为94.3%,均高于对照组的痊愈率48.6%、总有效率77.2%(P<0.05).治疗后,观察组细菌清除率为85.2%,高于对照组的65.4%(P0.05).结论 莫西沙星注射液联合痰热清注射液治疗老年CAP疗效显著,安全性好.“,”Objective To observe the clinical efficacy and safety of Tanreqing injection combined with moxifloxacin injection in the treatment of elderly patients with community acquired pneumonia.Methods 70 cases of elderly patients with community acquired pneumonia were randomly divided into observation group and control group,with 35 cases in each group.The observation group was given Tanreging injection combined with moxifloxacin injection while the control group was given moxifloxacin injection one time per day.Treatment course was 10 days for both groups.The clinical efficacy,bacterial clearance rate and the adverse reaction were observed and compared between the two groups.Results In obeservation group,the cure rate was 68.6% and the total effective rate was 94.3%,which were higher than that of control group with the cure rate was 48.6% and effective rate was 77.2% respectively(P0.05).Conclusion Tanreging injection combined with moxifloxacin injection in the treatment of elderly patients with community acquired pneumonia is an effective and SATE